Tavo Biotherapeutics
PrivateLast Round
Series A
Jun 2, 2026
Total Funding Raised
$29.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tavo Biotherapeutics is a biopharmaceutical company developing novel therapeutics for ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tavo Biotherapeutics Comparables
Compare Tavo Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Pharma | 88% | |
| RevOpsis Therapeutics | 82% | |
| Nicox S.A. | 72% | |
Tavo Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2026 | ||||
| Grant | Sep 1, 2024 |
Key People
Founding team and executive leadership
Tavo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Tau Capital | Series A, Seed |
| NIH RADx | Grant |
| Tennessee Technology Development Corporation | Grant |
| Pureos Bioventures | Series A |
| Polaris Partners | Series A |
| National Eye Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 58% MoM.
- Jul 17, 2026
Grew 36% QoQ, from 11 to 15 employees.
Tavo Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tavo Biotherapeutics's valuation, stock price, and market status.